| Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53. | None |
| The c-myb proto-oncogene: a novel target for human gene therapy. | None |
| Regulation of hematopoietic cell proliferation and differentiation by the myb oncogene family of transcription factors. | None |
| c-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation. | None |
| V-myb oncogene and c-myb proto-oncogene expression in avian cells: morphological changes of the cells and topographic localization of myb proteins. | None |
| Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb. | None |
| The importance of the linker connecting the repeats of the c-Myb oncoprotein may be due to a positioning function. | None |
| Isolation and characterization of a tobacco mosaic virus-inducible myb oncogene homolog from tobacco. | None |
| Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway. | None |
| The Myb oncoprotein: regulating a regulator. | None |
| Oncogenic point mutations induce altered conformation, redox sensitivity, and DNA binding in the minimal DNA binding domain of avian myeloblastosis virus v-Myb. | None |
| Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts. | None |
| Cytotoxic effect of sodium nitroprusside on cancer cells: involvement of apoptosis and suppression of c-myc and c-myb proto-oncogene expression. | None |
| Two regions in c-myb proto-oncogene product negatively regulating its DNA-binding activity. | None |
| The homeobox gene GBX2, a target of the myb oncogene, mediates autocrine growth and monocyte differentiation. | None |
| Regulating ancient regulators: the function of the B-Myb oncoprotein. | None |
| The c-Myb oncoprotein. | None |
| Oncoprotein v-Myb and retinoic acid receptor alpha are mutual antagonists. | None |